targeted protein degradation

Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Anika Sharma
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...